BRPI0408268A - moléculas e métodos de prevenção ou inibição da atividade da malária in vivo e de tratamento de pessoas - Google Patents
moléculas e métodos de prevenção ou inibição da atividade da malária in vivo e de tratamento de pessoasInfo
- Publication number
- BRPI0408268A BRPI0408268A BRPI0408268-0A BRPI0408268A BRPI0408268A BR PI0408268 A BRPI0408268 A BR PI0408268A BR PI0408268 A BRPI0408268 A BR PI0408268A BR PI0408268 A BRPI0408268 A BR PI0408268A
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- vivo
- preventing
- molecules
- treating people
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 230000000694 effects Effects 0.000 title abstract 2
- 201000004792 malaria Diseases 0.000 title abstract 2
- 238000001727 in vivo Methods 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 241000224016 Plasmodium Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000003494 hepatocyte Anatomy 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
"MOLECULAR E MéTODOS DE PREVENçãO OU INIBIçãO DA ATIVIDADE DA MALáRIA IN VIVO E DE TRATAMENTO DE PESSOAS". é provido método de prevenção da infecção de pessoas humanas por parasitas plasmódios. O método consiste na aplicação de compostos que interferem com a infecção de hepatócitos por Plasmodium viax.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45348303P | 2003-03-12 | 2003-03-12 | |
PCT/US2004/007516 WO2004080420A2 (en) | 2003-03-12 | 2004-03-11 | A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0408268A true BRPI0408268A (pt) | 2006-03-07 |
Family
ID=32990777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0408268-0A BRPI0408268A (pt) | 2003-03-12 | 2004-03-11 | moléculas e métodos de prevenção ou inibição da atividade da malária in vivo e de tratamento de pessoas |
Country Status (8)
Country | Link |
---|---|
US (1) | US7670631B2 (pt) |
EP (1) | EP1601378A2 (pt) |
JP (1) | JP2007525428A (pt) |
CN (1) | CN1809382A (pt) |
AP (1) | AP2005003411A0 (pt) |
BR (1) | BRPI0408268A (pt) |
WO (1) | WO2004080420A2 (pt) |
ZA (1) | ZA200508178B (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
EP2319518A1 (en) | 2002-02-04 | 2011-05-11 | ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. | Use of CO-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
US7968605B2 (en) | 2002-02-04 | 2011-06-28 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
GB2395432B (en) | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
CN1255106C (zh) * | 2003-09-26 | 2006-05-10 | 李国桥 | 复方青蒿素 |
GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
US7566465B2 (en) * | 2006-12-21 | 2009-07-28 | The United States Of America As Represented By The Secretary Of The Army | Artemisinins in the clinical and veterinary management of kinetoplastid infections |
WO2008147826A1 (en) * | 2007-05-22 | 2008-12-04 | Seattle Biomedical Research Institute | Malaria liver stage drugs |
CA2714121C (en) * | 2008-02-05 | 2016-03-22 | Forskarpatent I Syd Ab | Selection of rna-aptamers as anti-malaria agents |
WO2009111644A2 (en) * | 2008-03-05 | 2009-09-11 | The Regents Of The University Of Michigan | Compositions and methods for diagnosing and treating pancreatic cancer |
CA2772085A1 (en) * | 2009-08-27 | 2011-03-03 | The U.S.A., As Represented By The Secretary, Dept. Of Health And Human S Ervices | Compounds that treat malaria and prevent malaria transmission |
FR2952823B1 (fr) * | 2009-10-30 | 2012-04-20 | Sanofi Aventis | Utilisation de la ferroquine dans le traitement ou la prevention du paludisme |
WO2011074992A1 (en) * | 2009-12-15 | 2011-06-23 | Dec International Nz Limited | Treatment composition and method |
CN102811989A (zh) * | 2010-02-03 | 2012-12-05 | Meh联合公司 | 作为具有选择性和生物活性的等排物的多取代氟甲烷 |
EP2404601A1 (en) * | 2010-07-06 | 2012-01-11 | BioAgency AG | New drug combinations for the treatment of Malaria |
WO2012135064A2 (en) * | 2011-03-25 | 2012-10-04 | The Regents Of The University Of California | Attenuated strains of plasmodium |
ES2656237T3 (es) | 2011-04-19 | 2018-02-26 | Alfama, Inc. | Moléculas liberadoras de monóxido de carbono y usos de las mismas |
JP6134710B2 (ja) | 2011-07-21 | 2017-05-24 | アルファーマ インコーポレイテッドAlfama,Inc. | 一酸化ルテニウム放出分子およびその使用 |
US9169304B2 (en) | 2012-05-01 | 2015-10-27 | Pfenex Inc. | Process for purifying recombinant Plasmodium falciparum circumsporozoite protein |
WO2015006752A1 (en) * | 2013-07-12 | 2015-01-15 | The Regents Of The University Of California | Combination therapies for malaria |
WO2015178940A1 (en) * | 2014-05-20 | 2015-11-26 | American University Of Cairo (Auc) | Ligands that target plasmodium sporozoite binding sites on cd81 and therapeutic methods using them |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6344321B1 (en) * | 1990-06-11 | 2002-02-05 | Gilead Sciences, Inc. | Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met |
US6214344B1 (en) * | 1995-06-02 | 2001-04-10 | Genetech, Inc. | Hepatocyte growth factor receptor antagonists and uses thereof |
US6887499B2 (en) * | 2000-05-22 | 2005-05-03 | Enitan A. Bababunmi | Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease |
-
2004
- 2004-03-09 US US10/795,456 patent/US7670631B2/en not_active Expired - Fee Related
- 2004-03-11 JP JP2006507105A patent/JP2007525428A/ja active Pending
- 2004-03-11 CN CNA2004800119782A patent/CN1809382A/zh active Pending
- 2004-03-11 WO PCT/US2004/007516 patent/WO2004080420A2/en active Application Filing
- 2004-03-11 BR BRPI0408268-0A patent/BRPI0408268A/pt not_active IP Right Cessation
- 2004-03-11 AP AP2005003411A patent/AP2005003411A0/xx unknown
- 2004-03-11 EP EP04719810A patent/EP1601378A2/en not_active Withdrawn
-
2005
- 2005-10-10 ZA ZA200508178A patent/ZA200508178B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO2004080420A3 (en) | 2004-11-25 |
US20040185050A1 (en) | 2004-09-23 |
WO2004080420A2 (en) | 2004-09-23 |
JP2007525428A (ja) | 2007-09-06 |
AP2005003411A0 (en) | 2005-12-31 |
EP1601378A2 (en) | 2005-12-07 |
CN1809382A (zh) | 2006-07-26 |
ZA200508178B (en) | 2007-04-25 |
US7670631B2 (en) | 2010-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0408268A (pt) | moléculas e métodos de prevenção ou inibição da atividade da malária in vivo e de tratamento de pessoas | |
ATE472325T1 (de) | Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen | |
EP1455778A4 (en) | METHODS OF TREATING PERIPHERAL NEUROVASCULAR MALAYS | |
BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
ES2414872T8 (es) | Terapia combinada para la prevención o tratamiento de la enfermedad de Alzheimer y kit correspondiente | |
BRPI0509140A (pt) | processos para o tratamento de infecção por hiv | |
GB0223040D0 (en) | Therapeutic compounds | |
DE60114808D1 (de) | Oberflächenbehandlung von medizinischer vorrichtung | |
DE60031396D1 (de) | Zubereitung zur behandlung von einer neurologischen erkrankung | |
PL372925A1 (en) | Prevention and treatment of restenosis by local administration of drug | |
BRPI0407950A (pt) | processo para a preparação de uma composição de higiene pessoal | |
MY138883A (en) | Use of asiatic acid for treatment of cencer | |
BRPI0408491A (pt) | tratamento da doença de alzheimer | |
WO2005011572A3 (en) | Combination of drugs for the treatment of neoplasms | |
PT1218022E (pt) | Composicao para prevencao e/ou tratamento de doencas circulatorias compreendendo derivados de l-carnitina e extractos de ginkgo biloba | |
BRPI0408889A (pt) | uso de clusterina para o tratamento e/ou prevenção de doenças neurológicas periféricas | |
ATE357912T1 (de) | Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten | |
WO2006058298A3 (en) | A method of administering anti-angiogenic agents and a method of treating disease using same | |
CY1110043T1 (el) | 2-αμινοβενζουλ παραγωγα | |
EE200300328A (et) | IL-18 inhibiitorite kasutamine südamehaiguse raviks ja/või ennetamiseks | |
GB0020504D0 (en) | Therapeutic method | |
BR9814945A (pt) | Utilização de fanquinona para o tratamento de doença de alzheimer, composição farmacêutica e kit | |
EP1624786A4 (en) | METHOD FOR THE TREATMENT AND PREVENTION OF ILLNESSES OF BIOLOGICAL CHANNELS | |
PL373528A1 (en) | Medicine for preventing and treating bromidrosis | |
BR9908716A (pt) | Tratamento de disfunção sexual em certos grupos de pacientes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |